NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-194-2021-0-EP-06 Systems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging EP National Stage 22789416.9 Pending
NIAID E-266-2023-0-PC-01 Conductive Polymer Coated Electrodes for Dielectrophoretic Cell Positioning and Electroporation PCT PCT PCT/EP2024/056247 Pending
NCATS E-172-2021-0-AU-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES AU National Stage 2022345251 Pending
NEI E-194-2021-0-US-05 Systems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging US National Stage 18/690,130 Pending
NIDA E-036-2023-0-PCT-01 DUAL-TARGETED OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS PREPARATION AND USE THEREOF PCT PCT PCT/US2024/018704 Pending
NIBIB E-168-2021-2-JP-01 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL STRUCTURED ILLUMINATION MICROSCOPY WITH ISOTROPIC SPATIAL RESOLUTION IMPROVEMENT OF AXIAL RESOLUTION IN 3D SIM VIA OPTICAL AND COMPUTATIONAL MEANS JP National Stage 2024-514683 Pending
NICHD E-200-2021-0-AU-01 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE AU National Stage 2022379620 Pending
NCATS E-095-2018-0-CN-01 QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS CN DIV 202410240987.8 Pending
NICHD E-200-2021-0-CA-01 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE CA National Stage 3231009 Pending
NHLBI E-188-2021-0-US-02 ANTI-CMPL DIVALENT SCFV AND USES THEREOF US National Stage 18/688,899 Pending
NIDCR E-129-2021-0-EP-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction EP National Stage 22786210.9 Pending
NEI E-194-2021-0-CA-03 Systems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging CA National Stage 3230840 Pending
NIDCR E-129-2021-0-EA-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction EA National Stage 202490372 Pending
NCI E-169-2021-0-SG-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE SG National Stage 11202401449Q Pending
NCI E-048-2021-0-EP-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION EP National Stage 22758403.4 Pending
NCI E-169-2021-0-JP-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE JP National Stage 2024-513749 Pending
NIDCR E-129-2021-0-KR-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction KR National Stage 10-2024-7007179 Pending
NCI E-169-2021-0-US-02 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE US National Stage 18/688,126 Pending
NIDCR E-129-2021-0-AP-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction AP National Stage AP/P/2024/015557 Pending
NCI E-175-2016-0-CN-01 ANTI-KRAS-G12D T CELL RECEPTORS CN DIV 202410214235.4 Pending
NIDCR E-129-2021-0-CN-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction CN National Stage 202280058429.9 Pending
NIDCR E-129-2021-0-ZA-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction ZA National Stage 2024/01677 Pending
NLM E-107-2010-2-US-38 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 18/588,930 Pending
NLM E-107-2010-2-US-40 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 18/588,956 Pending
NLM E-107-2010-2-US-39 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 18/588,987 Pending
NIDCR E-129-2021-0-AU-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction AU National Stage 2022325158 Pending
NIDCR E-129-2021-0-NZ-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction NZ National Stage 808619 Pending
NIAID E-052-2017-4-HK-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection HK CN 42024087670.6 Pending
NIEHS E-022-2023-0-PC-01 MUTANT ARA H 2 AND ARA H 6 PROTEINS AND USES THEREOF PCT PCT PCT/US2024/017072 Pending
NCI E-169-2021-0-AU-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE AU National Stage 2022340743 Pending
NEI E-194-2021-0-AU-04 Systems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging AU National Stage 2022344259 Pending
NCI E-237-2017-2-US-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 US DIV 18/583,139 Pending
NCI E-169-2021-0-CA-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE CA National Stage 3229861 Pending
NCATS E-095-2018-0-IN-01 QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS IN DIV 202418011832 Pending
NIAID E-228-2016-1-CN-18 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof CN DIV 202410185751.9 Pending
NIAID E-081-2013-4-IN-26 Prefusion RSV F Proteins And Their Use IN DIV 202438010632 Pending
NIAID E-001-2017-1-US-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US CON 18/440,344 Pending
NCI E-233-2014-0-JP-01 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2024-018658 Pending
NIDCD E-043-2016-0-CN-08 MICRORNAS AND METHODS OF THEIR USE CN DIV 202410174429.6 Pending
NIDCD E-043-2016-0-CN-09 MICRORNAS AND METHODS OF THEIR USE CN DIV 202410174426.2 Pending
NIAID E-241-2014-0-JP-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof JP DIV 2024-016880 Pending
NIAID E-106-2016-0-US-06 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE
RESPONSE 		US CON 18/432,637 Pending
NEI E-164-2021-0-EP-01 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY EP National Stage 22838435.0 Pending
NCATS E-244-2014-0-US-02 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US CON 18/433,099 Pending
NINDS E-117-2021-1-US-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. US National Stage 18/294,663 Pending
NCI E-048-2021-0-US-02 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION US National Stage 18/681,019 Pending
NCATS E-198-2016-0-EP-01 NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING EP DIV 24155493.0 Pending
NCI E-067-2017-0-HK-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES HK EP 42024086425.6 Pending
NIDCR E-129-2021-0-JP-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction JP National Stage 2024-506727 Pending
NIDCR E-129-2021-0-MY-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction MY National Stage PI2024000751 Pending